Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -56.53% is 24% above its 5-year average of -74.08%, near the high end of its 5-year range (-261.95%–-14.27%).
As of the fiscal period ended Tuesday, June 30, 2026. 60.49% above its 12-month average of -143.07%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -56.53%.
RETURN ON INVESTED CAPITAL (ROIC)
-56.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-143.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-101.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-74.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+60.49%
CURRENT VS 3Y AVG
+44.55%
CURRENT VS 5Y AVG
+23.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
-64.15%
vs the sector median at left
ALX Oncology Holdings Inc.
Market Cap
$152.06M
Return on Invested Capital (ROIC)
-56.53%
TTM Avg
-143.07%
3Y Avg
-101.93%
5Y Avg
-74.08%
Market Cap
$151.15M
Return on Invested Capital (ROIC)
-23.41%
TTM Avg
-38.99%
3Y Avg
-40.72%
5Y Avg
-30.95%
Market Cap
$151.58M
Return on Invested Capital (ROIC)
-165.56%
TTM Avg
-176.54%
3Y Avg
-127.81%
5Y Avg
-112.12%
Market Cap
$155.53M
Return on Invested Capital (ROIC)
-22.15%
TTM Avg
-29.24%
3Y Avg
-31.64%
5Y Avg
-30.48%
Market Cap
$162.60M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-138.87%
3Y Avg
-97.17%
5Y Avg
-81.85%
Market Cap
$149.18M
Return on Invested Capital (ROIC)
-223.90%
TTM Avg
-825.42%
3Y Avg
-606.12%
5Y Avg
-416.73%
Market Cap
$156.90M
Return on Invested Capital (ROIC)
-13.94%
TTM Avg
-16.11%
3Y Avg
-25.11%
5Y Avg
-17.04%
Market Cap
$148.31M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-52.39%
3Y Avg
-55.03%
5Y Avg
-91.26%
Market Cap
$147.34M
Return on Invested Capital (ROIC)
-118.67%
TTM Avg
-87.91%
3Y Avg
-55.09%
5Y Avg
-41.64%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc. (ALXO) | $152.06M | -56.53% | -143.07% | -101.93% | -74.08% |
| Codexis, Inc. (CDXS)vs › | $151.15M | -23.41% | -38.99% | -40.72% | -30.95% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | -165.56% | -176.54% | -127.81% | -112.12% |
| Neuronetics, Inc. (STIM)vs › | $155.53M | -22.15% | -29.24% | -31.64% | -30.48% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $162.60M | N/A | -138.87% | -97.17% | -81.85% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $149.18M | -223.90% | -825.42% | -606.12% | -416.73% |
| Inogen, Inc. (INGN)vs › | $156.90M | -13.94% | -16.11% | -25.11% | -17.04% |
| LifeMD, Inc. (LFMDP)vs › | $148.31M | -143.97% | -52.39% | -55.03% | -91.26% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $147.34M | -118.67% | -87.91% | -55.09% | -41.64% |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.63M | -38.56% | -39.74% | -42.41% | -37.88% |
ROIC
-56.5%
ROE
-59.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -56.53% |
| 2026-03-31 | -55.81% |
| 2025-12-31 | -261.95% |
| 2025-09-30 | -188.06% |
| 2025-06-30 | -152.99% |
| 2025-03-31 | -131.40% |
| 2024-12-31 | -109.84% |
| 2024-09-30 | -104.24% |
| 2024-06-30 | -101.50% |
| 2024-03-31 | -96.50% |
| 2023-12-31 | -82.44% |
| 2023-09-30 | -83.52% |
| 2023-06-30 | -60.38% |
| 2023-03-31 | -52.64% |
| 2022-12-31 | -45.81% |
| 2022-09-30 | -42.29% |
| 2022-06-30 | -34.65% |
| 2022-03-31 | -27.01% |
| 2021-12-31 | -22.90% |
| 2021-09-30 | -18.83% |
| 2021-06-30 | -14.27% |
| 2021-03-31 | -12.57% |
| 2020-12-31 | -10.16% |
| 2020-09-30 | -13.02% |
| 2020-06-30 | -27.59% |
| 2020-03-31 | -19.19% |
| 2019-12-31 | -337.02% |
